We are live on ! Find out more
FLAM

First Light Asset Management Portfolio holdings

AUM $1.12B
1-Year Est. Return 114.45%
This Fund
S&P 500
This Quarter Est. Return
+26.49%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$988M
AUM Growth
+$129M
Cap. Flow
+$16.3M
Cap. Flow %
1.65%
Top 10 Hldgs %
50.06%
Holding
77
New
6
Increased
26
Reduced
14
Closed
6

Top Buys

Rank Stock Value
1
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$29.2M
2
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
+$8.2M
3
LABU icon
Direxion Daily S&P Biotech Bull 3X ETF
LABU
+$7.86M
4
TMDX icon
Transmedics
TMDX
+$6.69M
5
MIRM icon
Mirum Pharmaceuticals
MIRM
+$5.9M

Top Sells

Rank Stock Value
1
PRTA icon
Prothena Corp
PRTA
+$12.6M
2
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
+$10.6M
3
KRYS icon
Krystal Biotech
KRYS
+$7.45M
4
CDXS icon
Codexis
CDXS
+$7.17M
5
CDNA icon
CareDx
CDNA
+$4.87M

Sector Composition

Rank Sector Weight
1 Healthcare 86.29%
2 Communication Services 9.04%
3 Energy 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRTA icon
1
Prothena Corp
PRTA
$425M
$93.3M 9.44%
1,538,678
-399,505
-21% -$12.6M
MODN
2
DELISTED
MODEL N, INC.
MODN
$89.3M 9.04%
2,608,221
-145,537
-5% -$4.21M
ATRC icon
3
AtriCure
ATRC
$1.92B
$58.4M 5.91%
1,494,655
+15,029
+1% +$688K
SPNE
4
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
$40.1M 4.06%
7,067,572
+37,263
+0.5% +$237K
KRTX
5
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$37.4M 3.79%
166,316
+40,523
+32% +$8.2M
HALO icon
6
Halozyme
HALO
$9.79B
$36.9M 3.73%
932,244
-9,001
-1% -$398K
SIBN icon
7
SI-BONE Inc
SIBN
$788M
$35.4M 3.58%
2,027,963
+21,659
+1% +$346K
CUTR
8
DELISTED
Cutera, Inc.
CUTR
$34.8M 3.52%
763,180
-8,634
-1% -$394K
AXGN icon
9
Axogen
AXGN
$2.27B
$34.7M 3.51%
2,911,824
-113,295
-4% -$1.13M
KRYS icon
10
Krystal Biotech
KRYS
$10.1B
$34.3M 3.47%
492,555
-103,057
-17% -$7.45M
OMCL icon
11
Omnicell
OMCL
$1.61B
$30.4M 3.07%
349,106
+2,077
+0.6% +$218K
RETA
12
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$26.5M 2.68%
+1,054,985
New +$29.2M
CRNX icon
13
Crinetics Pharmaceuticals
CRNX
$8.84B
$26.4M 2.68%
1,346,652
+106,043
+9% +$2.16M
ATEC icon
14
Alphatec Holdings
ATEC
$1.46B
$26M 2.63%
2,974,658
+49,694
+2% +$393K
BLU
15
DELISTED
BELLUS Health Inc.
BLU
$25.2M 2.55%
2,381,857
-26,217
-1% -$279K
NEO icon
16
NeoGenomics
NEO
$1.96B
$23.4M 2.37%
2,720,099
+4,612
+0.2% +$45.8K
TNDM icon
17
Tandem Diabetes Care
TNDM
$1.34B
$23.2M 2.35%
485,620
+18,065
+4% +$990K
KROS icon
18
Keros Therapeutics
KROS
$199M
$22.5M 2.28%
598,213
-120
-0% -$4.16K
AXNX
19
DELISTED
Axonics, Inc. Common Stock
AXNX
$22.3M 2.26%
316,809
+2,805
+0.9% +$193K
FNA
20
DELISTED
Paragon 28, Inc.
FNA
$22.1M 2.23%
1,238,055
+544
+0% +$10K
PLRX icon
21
Pliant Therapeutics
PLRX
$64.4M
$20.2M 2.04%
965,114
+195,744
+25% +$3.75M
RARE icon
22
Ultragenyx Pharmaceutical
RARE
$2.45B
$18.8M 1.9%
453,794
+1,324
+0.3% +$68K
BCYC
23
Bicycle Therapeutics
BCYC
$269M
$16.4M 1.66%
704,721
+439
+0.1% +$10.4K
INSM icon
24
Insmed
INSM
$21.4B
$16.3M 1.65%
756,417
-5,765
-0.8% -$138K
KIDS icon
25
OrthoPediatrics
KIDS
$519M
$14.2M 1.44%
308,728
-5,996
-2% -$294K
1
2 3 4

Similar funds

AIM
Advyzon Investment Management Lisle, Illinois $1.12B AUM 22.08% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return
CNC
Canandaigua National Corp Canandaigua, New York $1.12B AUM
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
RIM
Rockbridge Investment Management Syracuse, New York $1.11B AUM 13.62% 1-Year Est. Return
CT
Caldwell Trust Venice, Florida $1.12B AUM 21.31% 1-Year Est. Return
SL
Salomon & Ludwin Richmond, Virginia $1.12B AUM 14.38% 1-Year Est. Return
HH
Hilltop Holdings Dallas, Texas $1.11B AUM 24.7% 1-Year Est. Return

First Light Asset Management's Q3 2022 Portfolio in Review

As of Q3 2022, First Light Asset Management held 77 positions worth $988M, up 15% from $859M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

First Light Asset Management's Q3 2022 filing shows 6 new, 26 increased, 14 reduced and 6 closed positions. Its largest new stake was Reata Pharmaceuticals, Inc. Class A Common Stock: 1,054,985 shares worth $26.5M. The largest sale was Prothena Corp, an estimated $12.6M.

By sector, the portfolio is most concentrated in Healthcare at 86% of assets, down from 87% a quarter earlier, followed by Communication Services and Energy.

  • First Light Asset Management's largest Q3 2022 buy was Reata Pharmaceuticals, Inc. Class A Common Stock: 1,054,985 shares worth $26.5M.
  • First Light Asset Management added most to Karuna Therapeutics, Inc. Common Stock in Q3 2022, an estimated $8.2M increase.
  • First Light Asset Management's biggest Q3 2022 reduction was Prothena Corp, cutting an estimated $12.6M.
  • First Light Asset Management fully exited Turning Point Therapeutics, Inc. Common Stock in Q3 2022, selling an estimated $10.6M.
  • First Light Asset Management's ten largest holdings make up 50% of its $988M portfolio in Q3 2022.
  • First Light Asset Management opened 6 new positions and closed 6 in Q3 2022.
  • First Light Asset Management's portfolio value rose 15% quarter-over-quarter to $988M.

Based on First Light Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.